Search results for:assisted more
Multiple Myeloma: Treatment and Medications
Being the second most common type of blood cancer, 5-6% of the world population is diagnosed with Multiple Myeloma every […]
ikrisuser
December 8, 2020
FDA Approves Margenza Plus Chemo in Metastatic HER2+ Breast Cancer
The FDA has approved Margenza plus chemo for adult patients with metastatic HER2+ breast cancer who have previously treated with […]
ikrisuser
February 17, 2021
Rare Diseases: Challenges and preventions to control
Diseases that affect a very small proportion of the population of a state, rare diseases are also known as orphan […]
ikrisuser
February 28, 2022Study of Cytarabine Injection: A Chemotherapy Medication
What is Cytarabine? Cytarabine is an anti-cancer medication. Cytarabine chemotherapy injection is used for the treatment of some types of […]
ikrisuser
August 17, 2021
Towards a ‘healthy’ pharmaceutical partnership: India-Africa
According to the Government of India’s estimates, the Indian pharmaceuticals industry is the third-largest in volume and the 13th largest […]
ikrisuser
April 26, 2022How Immunokris will help in Boosting Immune System
The immune system is specifically a network of cells, tissues, and organs that primarily work together in order to defend […]
ikrisuser
June 1, 2021
A comparison of Covid-19 vaccines
In the outgoing race to prevent the coronavirus pandemic, zillions of people in dozens of nations have started to receive […]
ikrisuser
February 8, 2021
Ocular Management of Cystinosis
Nephropathic cystinosis specifically is a rare, inherited autosomal recessive disease developed due to the cystine accumulation in lysosomes. A dysfunctional […]
ikrisuser
January 18, 2022
Monkeypox clusters emergence in Europe and reach in North; worry for India?
Monkeypox, a rare viral zoonosis (a virus transmitted to humans from animals) disease primarily associated with the tropical rainforests of […]
ikrisuser
May 23, 2022Teclistamab Demonstrates Continued Promise in Relapsed/Refractory MM
According to outcomes from an ongoing phase 1 study, a bispecific BCMA (B-cell maturation antigen) x CD3 antibody named Teclistamab […]
